BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, January 16, 2026
Home
»
Authors
» Jennifer Boggs
Jennifer Boggs
Articles
ARTICLES
Corgentech Cuts Staff To Slow Spending After E2F Decoy Miss
April 21, 2005
By
Jennifer Boggs
Agennix Reports Positive NSCLC Data With Talactoferrin, Chemo
April 20, 2005
By
Jennifer Boggs
Agennix Reports Positive NSCLC Data With Talactoferrin, Chemo
April 20, 2005
By
Jennifer Boggs
Nuvelo Begins Phase III Trial Of Alfimeprase In 'Leg Attack'
April 19, 2005
By
Jennifer Boggs
Nuvelo Begins Phase III Trial Of Alfimeprase In 'Leg Attack'
April 19, 2005
By
Jennifer Boggs
Acadia Raising $36M Privately For Parkinson's, Schizophrenia Work
April 18, 2005
By
Jennifer Boggs
Acadia Raising $36M Privately For Parkinson's, Schizophrenia Work
April 18, 2005
By
Jennifer Boggs
Xsira Licenses Clinical-Stage Adenosine-Based Compound
April 15, 2005
By
Jennifer Boggs
Xsira Licenses Clinical-Stage Adenosine-Based Compound
April 15, 2005
By
Jennifer Boggs
Omeros' Lead Anti-Inflammatory Drug Moves Into Phase III Study
April 14, 2005
By
Jennifer Boggs
View All Articles by Jennifer Boggs
